ANDOVER,
Mass., Aug. 21, 2024 /PRNewswire/
-- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a
medical technology company that is transforming organ transplant
therapy for patients with end-stage lung, heart, and liver failure,
today announced that members of the management team will
participate in a fireside chat at the upcoming Morgan Stanley
22nd Annual Global Healthcare Conference at the Marriott
Marquis New York. The fireside chat will take place on Wednesday, September 4, 2024, at 1:05 p.m. Eastern Time.
Event: Morgan Stanley 22nd Annual Global
Healthcare Conference
Date: Wednesday, September 4, 2024
Time: 1:05 p.m. ET
A live and archived webcast of the fireside chat will be
available on the "Investors" section of the TransMedics website at
https://investors.transmedics.com. The Company's standard investor
presentation is also available through this link.
About TransMedics Group, Inc.
TransMedics is the
world's leader in portable extracorporeal warm perfusion and
assessment of donor organs for transplantation. Headquartered in
Andover, Massachusetts, the
company was founded to address the unmet need for more and better
organs for transplantation and has developed technologies to
preserve organ quality, assess organ viability prior to transplant,
and potentially increase the utilization of donor organs for the
treatment of end-stage heart, lung, and liver failure.
Investor Contact:
Brian
Johnston
332-895-3222
Investors@transmedics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-morgan-stanley-22nd-annual-global-healthcare-conference-302227550.html
SOURCE TransMedics Group, Inc.
